Pictet Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.89M | Buy |
590,151
+156,917
| +36% | +$2.63M | 0.01% | 656 |
|
|
2025
Q1 | $6.65M | Sell |
433,234
-165,253
| -28% | -$2.54M | 0.01% | 750 |
|
|
2024
Q4 | $13.2M | Buy |
598,487
+52,938
| +10% | +$1.17M | 0.01% | 598 |
|
|
2024
Q3 | $9.83M | Buy |
545,549
+106,639
| +24% | +$1.92M | 0.01% | 657 |
|
|
2024
Q2 | $7.13M | Buy |
438,910
+32,047
| +8% | +$521K | 0.01% | 710 |
|
|
2024
Q1 | $5.74M | Buy |
406,863
+22,543
| +6% | +$318K | 0.01% | 755 |
|
|
2023
Q4 | $4.01M | Sell |
384,320
-4,802
| -1% | -$50.1K | ﹤0.01% | 826 |
|
|
2023
Q3 | $3.97M | Buy |
+389,122
| New | +$3.97M | ﹤0.01% | 816 |
|